兽用辅料市场－全球产业规模、份额、趋势、机会及预测（依应用、化学类别、动物种类、最终用途、地区及竞争格局划分，2021-2031年）

全球兽用添加剂市场预计将从 2025 年的 21.1 亿美元成长到 2031 年的 28.1 亿美元，复合年增长率为 4.82%。

这些辅料是药理学上惰性的物质，与活性成分混合使用，以改善动物用药品的稳定性、生物利用度和口感。市场扩张的主要驱动力是全球对动物性蛋白质日益增长的需求，以及需要先进治疗方案的伴侣动物数量显着增加。此外，通用感染疾病率的上升也加速了对有效兽药的需求，从而推动了对功​​能性辅料的需求。根据美国宠物用品协会（APPA）的数据，预计到2024年，美国宠物产业的总支出将达到1,520亿美元，饲主对动物福利的坚定经济投入将支撑该产业的成长。

儘管有这些有利条件，但由于各地区法规结构严格且差异较大，市场仍面临许多挑战。製造商在遵守FDA和EMA等监管机构制定的复杂合规标准方面面临诸多挑战，这会延长研发週期并增加生产成本。这种监管复杂性可能对新型辅料构成重大准入壁垒，抑制创新，并限制新兴市场（目前兽药标准正在製定中）获得经济高效的解决方案。

市场驱动因素

全球宠物饲养量的增加和动物拟人化的趋势正在加速对先进口服固体製剂和偏好给药系统的需求，从根本上改变了兽用辅料的市场结构。随着宠物饲主越来越将宠物视为家庭成员，关节炎和糖尿病等慢性疾病的治疗需求显着增加，需要长期用药管理。这一趋势促使製造商利用先进的功能性添加剂，特别是掩味剂和崩坏，将传统的动物医药转化为宠物可食用的咀嚼片和零食。对先进兽医护理的经济投入也体现在快速成长的保险业。根据北美宠物健康保险协会于2024年4月发布的《2024年产业趋势报告》，预计2023年北美宠物保险总保费将达到创纪录的42.7亿美元，显示高品质药物製剂市场需求旺盛。

同时，集约化畜牧业的扩张也成为推动这一趋势的重要因素，对疫苗、药用饲料添加剂和注射剂等产品中使用的经济高效的添加剂产生了巨大的需求。为了维持高密度畜群的生产力和粮食安全，生产者高度依赖预防性治疗，而添加剂则作为关键的稳定剂和载体，确保药物在实际生产条件下的疗效。这种依赖性在生产预测中显而易见。根据美国农业部海外农业局2024年10月发布的《畜牧与家禽：全球市场与贸易》报告，预计2025年全球鸡肉出口量将达到创纪录的1,380万吨，反映出支撑庞大添加剂市场的生产系统面临巨大的压力。主要企业的数据进一步凸显了该产业对药品的巨大需求。硕腾公司报告称，该公司2023财年的全年收入在2024年达到85亿美元，显示其庞大的产业规模需要稳定的药品原料供应。

市场挑战

严格且分散的区域监管环境是限制全球兽用辅料市场成长的主要障碍。製造商必须遵守美国食品药物管理局 (FDA) 和欧洲药品管理局 (EMA) 等机构制定的不同合规要求，这些要求通常涉及对辅料安全性和有效性的广泛且重迭的检验流程。这种监管差异显着增加了生产成本并延长了研发週期，从而减缓了新型辅料在动物医药製剂中的应用。这些不断增长的资源需求构成了重要的准入壁垒，对中小企业的影响尤其严重，并阻碍了整个产业的创新速度。

此外，监管核准的复杂性限制了先进治疗方案在关键市场（这些市场对成本效益最为重视）的广泛应用。无法快速部署符合规定的製剂直接影响了严重依赖现有动物用药品的终端用户产业的生产力。根据澳洲动物药品协会预测，畜牧业预计到2024年将为农业生产贡献376亿美元，这一数字凸显了规模经济的重要性，而规模经济依赖于高品质动物用药品的高效核准和供应。因此，监管效率低下不仅阻碍了市场扩张，也威胁到这些辅料所支持的产业的经济稳定。

市场趋势

随着兽用生技药品领域，特别是单株抗体和聚合物疫苗的快速扩张，高纯度辅料的研发也正在加速推进。与传统的小分子药物不同，这些复杂的製剂需要特殊的稳定剂，例如药用级界面活性剂、缓衝剂和冷冻保护剂，以在冷冻干燥和储存过程中保持其有效性。这项技术需求正推动着对专门用于处理敏感生物成分的生产能力进行大量资本投资，这与标准的化学生产截然不同。根据默克动物保健公司2025年5月发布的题为「默克动物保健公司与堪萨斯州宣布8.95亿美元投资」的新闻稿，该公司宣布将投资8.95亿美元用于扩建其位于堪萨斯州德索託的工厂，专门用于提升生物製药和疫苗的灌装和冻干能力。

同时，在大型动物用药品公司严格的环境、社会和管治(ESG) 要求的推动下，市场正经历着向永续和可生物降解辅料的根本性转变。製造商正加强对其供应链的审查，以减少范围 3 的排放，并优先使用可再生原料而非石油化学衍生的聚合物，从而最大限度地减少其对环境的影响。这项产业范围内的脱碳策略正在对辅料供应商提出一系列要求，要求他们检验其产品的碳足迹和生物降解性，以确保符合关键的采购标准。硕腾公司于 2025 年 6 月发布的《2024 年永续发展进展报告》显示，该公司将使用 80.6% 的全球整体电力来自再生能源来源，这表明绿色转型正在重塑医药原料的采购标准，其规模之大令人瞩目。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球兽用辅料市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依应用领域（生物製药、药品、药用饲料添加剂）
  • 依化学基团分类（聚合物、醇类、脂质、无机盐等）
  • 动物类型（生产动物、伴侣动物）
  • 依用途分类（增溶剂/溶剂、粘合剂、稳定剂、涂层剂、稀释剂/填料等）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美兽用辅料市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲兽用辅料市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区兽用辅料市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲兽用辅料市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美兽用辅料市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球兽用辅料市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Croda International plc
• JRS PHARMA GmbH+Co. KG
• Colorcon
• Quality Chemicals SL
• IOI Oleo GmbH
• Lipoid GmbH
• Gattefosse SAS
• Azelis Group
• Ashland Global Holdings Inc.
• Spectrum Chemical Mfg. Corp.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Veterinary Excipients Market is projected to expand from USD 2.11 Billion in 2025 to USD 2.81 Billion by 2031, reflecting a compound annual growth rate of 4.82%. These excipients are pharmacologically inert substances formulated with active pharmaceutical ingredients to improve the stability, bioavailability, and taste of animal health products. The market's expansion is primarily driven by the escalating global demand for animal-derived protein and a substantial increase in companion animal ownership, which requires sophisticated therapeutic options. Furthermore, the rising incidence of zoonotic diseases has accelerated the need for effective veterinary formulations, thereby boosting the demand for functional excipients. Data from the American Pet Products Association indicates that total U.S. pet industry expenditures hit $152 billion in 2024, demonstrating the strong financial dedication of owners to animal welfare that supports this sector's growth.

Despite these positive conditions, the market encounters a major hurdle due to strict and varying regulatory frameworks across different regions. Manufacturers face the challenge of adhering to complex compliance standards established by authorities such as the FDA and EMA, which can extend development timelines and inflate production costs. This regulatory complexity acts as a formidable barrier to entry for new excipients, potentially curbing innovation and restricting the availability of cost-effective solutions in emerging markets where veterinary standards are currently evolving.

Market Driver

The trends of rising global pet ownership and the humanization of animals are fundamentally altering the veterinary excipients landscape by accelerating the demand for sophisticated oral solid dosage forms and palatable delivery systems. As pet owners increasingly regard their companions as family members, there is a distinct shift toward treating chronic conditions such as arthritis and diabetes, necessitating long-term medication adherence. This trend compels manufacturers to utilize advanced functional excipients, particularly taste-masking agents and disintegrants, to transform traditional veterinary drugs into pet-friendly chewables and treats. The financial commitment to advanced veterinary care is evident in the surging insurance sector; according to the North American Pet Health Insurance Association's 'State of the Industry Report 2024' released in April 2024, total pet insurance premiums in North America reached a record $4.27 billion in 2023, signaling a robust market for premium pharmaceutical formulations.

Simultaneously, the expansion of intensive livestock farming operations acts as a parallel driver, creating high-volume demand for cost-effective excipients used in vaccines, medicated feed additives, and injectables. To maintain productivity and food security within densely populated herds, producers rely heavily on prophylactic treatments, where excipients act as critical stabilizers and carriers to ensure drug efficacy under field conditions. This reliance is underscored by production forecasts; according to the USDA Foreign Agricultural Service's October 2024 'Livestock and Poultry: World Markets and Trade' report, global chicken meat exports are forecast to rise to a record 13.8 million tons in 2025, reflecting the intense pressure on production systems that sustains the bulk excipient market. The immense scale of pharmaceutical requirements in this sector is further highlighted by leading manufacturers; according to Zoetis, in 2024, the company reported full-year revenue of $8.5 billion for 2023, illustrating the substantial industrial footprint requiring a steady supply of pharmaceutical ingredients.

Market Challenge

The stringent and fragmented regulatory landscape across different regions constitutes a primary obstacle hampering the growth of the Global Veterinary Excipients Market. Manufacturers must adhere to disparate compliance requirements enforced by agencies such as the FDA and EMA, which often necessitates extensive and redundant validation processes for excipient safety and efficacy. This regulatory divergence significantly escalates production costs and prolongs development timelines, thereby reducing the speed at which novel excipients can be integrated into finished veterinary formulations. These elevated resource demands act as a substantial barrier to entry, disproportionately affecting smaller enterprises and stifling the overall rate of innovation within the industry.

Furthermore, the complexity of securing regulatory approval limits the availability of advanced therapeutic options in key markets where cost-efficiency is paramount. The inability to rapidly deploy compliant formulations directly affects the productivity of end-use sectors that rely heavily on accessible veterinary medicines. According to Animal Medicines Australia, in 2024, the livestock industry was forecast to contribute $37.6 billion to agricultural production, a figure that highlights the critical economic volume dependent on the efficient approval and supply of high-quality animal health products. Consequently, regulatory inefficiencies not only hinder market expansion but also threaten the economic stability of the industries these excipients serve.

Market Trends

The development of high-purity excipients is accelerating due to the rapid expansion of the veterinary biologics sector, particularly for monoclonal antibodies and large-molecule vaccines. Unlike traditional small-molecule drugs, these complex formulations require specialized stabilizing agents, such as pharmaceutical-grade surfactants, buffers, and cryoprotectants, to maintain efficacy during freeze-drying and storage. This technical necessity is driving significant capital expenditure in manufacturing capabilities designed specifically to handle sensitive biological ingredients, distinct from standard chemical production. According to Merck Animal Health, May 2025, in the press release 'Merck Animal Health and State of Kansas Announce $895 Million Investment', the company committed $895 million to expand its De Soto, Kansas facility, specifically enhancing filling and freeze-drying capacity for biologics and vaccines.

Concurrently, the market is witnessing a fundamental shift toward sustainable and biodegradable excipients, compelled by the rigorous environmental, social, and governance (ESG) mandates of leading animal health corporations. Manufacturers are increasingly scrutinizing their supply chains to reduce Scope 3 emissions, prioritizing ingredients derived from renewable sources over petrochemical-based polymers to minimize their environmental impact. This industry-wide decarbonization strategy creates a cascading requirement for excipient suppliers to validate the carbon footprint and biodegradability of their portfolios to remain compliant with major procurement standards. According to Zoetis, June 2025, in the '2024 Sustainability Progress Update', the company reported sourcing 80.6% of its global electricity from renewable sources, illustrating the scale of the green transition that is reshaping procurement criteria for pharmaceutical ingredients.

Key Market Players

• Croda International plc
• JRS PHARMA GmbH + Co. KG
• Colorcon
• Quality Chemicals S.L
• IOI Oleo GmbH
• Lipoid GmbH
• Gattefosse SAS
• Azelis Group
• Ashland Global Holdings Inc.
• Spectrum Chemical Mfg. Corp.

Report Scope

In this report, the Global Veterinary Excipients Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Excipients Market, By Application

• Biologics
• Pharmaceuticals
• Medicated Feed Additives

Veterinary Excipients Market, By Chemical Group

• Polymers
• Alcohols
• Lipids
• Mineral Salts
• Others

Veterinary Excipients Market, By Animal Type

• Production Animals
• Companion Animals

Veterinary Excipients Market, By End Use

• Solubilizers/ Solvents
• Binders
• Stabilizers
• Coating
• Diluents & fillers
• Others

Veterinary Excipients Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Excipients Market.

Available Customizations:

Global Veterinary Excipients Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Veterinary Excipients Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Application (Biologics, Pharmaceuticals, Medicated Feed Additives)
  • 5.2.2. By Chemical Group (Polymers, Alcohols, Lipids, Mineral Salts, Others)
  • 5.2.3. By Animal Type (Production Animals, Companion Animals)
  • 5.2.4. By End Use (Solubilizers/ Solvents, Binders, Stabilizers, Coating, Diluents & fillers, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Veterinary Excipients Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Application
  • 6.2.2. By Chemical Group
  • 6.2.3. By Animal Type
  • 6.2.4. By End Use
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Veterinary Excipients Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Application
      • 6.3.1.2.2. By Chemical Group
      • 6.3.1.2.3. By Animal Type
      • 6.3.1.2.4. By End Use
  • 6.3.2. Canada Veterinary Excipients Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Application
      • 6.3.2.2.2. By Chemical Group
      • 6.3.2.2.3. By Animal Type
      • 6.3.2.2.4. By End Use
  • 6.3.3. Mexico Veterinary Excipients Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Application
      • 6.3.3.2.2. By Chemical Group
      • 6.3.3.2.3. By Animal Type
      • 6.3.3.2.4. By End Use

7. Europe Veterinary Excipients Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Application
  • 7.2.2. By Chemical Group
  • 7.2.3. By Animal Type
  • 7.2.4. By End Use
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Veterinary Excipients Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Application
      • 7.3.1.2.2. By Chemical Group
      • 7.3.1.2.3. By Animal Type
      • 7.3.1.2.4. By End Use
  • 7.3.2. France Veterinary Excipients Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Application
      • 7.3.2.2.2. By Chemical Group
      • 7.3.2.2.3. By Animal Type
      • 7.3.2.2.4. By End Use
  • 7.3.3. United Kingdom Veterinary Excipients Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Application
      • 7.3.3.2.2. By Chemical Group
      • 7.3.3.2.3. By Animal Type
      • 7.3.3.2.4. By End Use
  • 7.3.4. Italy Veterinary Excipients Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Application
      • 7.3.4.2.2. By Chemical Group
      • 7.3.4.2.3. By Animal Type
      • 7.3.4.2.4. By End Use
  • 7.3.5. Spain Veterinary Excipients Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Application
      • 7.3.5.2.2. By Chemical Group
      • 7.3.5.2.3. By Animal Type
      • 7.3.5.2.4. By End Use

8. Asia Pacific Veterinary Excipients Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Application
  • 8.2.2. By Chemical Group
  • 8.2.3. By Animal Type
  • 8.2.4. By End Use
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Veterinary Excipients Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Application
      • 8.3.1.2.2. By Chemical Group
      • 8.3.1.2.3. By Animal Type
      • 8.3.1.2.4. By End Use
  • 8.3.2. India Veterinary Excipients Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Application
      • 8.3.2.2.2. By Chemical Group
      • 8.3.2.2.3. By Animal Type
      • 8.3.2.2.4. By End Use
  • 8.3.3. Japan Veterinary Excipients Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Application
      • 8.3.3.2.2. By Chemical Group
      • 8.3.3.2.3. By Animal Type
      • 8.3.3.2.4. By End Use
  • 8.3.4. South Korea Veterinary Excipients Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Application
      • 8.3.4.2.2. By Chemical Group
      • 8.3.4.2.3. By Animal Type
      • 8.3.4.2.4. By End Use
  • 8.3.5. Australia Veterinary Excipients Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Application
      • 8.3.5.2.2. By Chemical Group
      • 8.3.5.2.3. By Animal Type
      • 8.3.5.2.4. By End Use

9. Middle East & Africa Veterinary Excipients Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Application
  • 9.2.2. By Chemical Group
  • 9.2.3. By Animal Type
  • 9.2.4. By End Use
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Veterinary Excipients Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Application
      • 9.3.1.2.2. By Chemical Group
      • 9.3.1.2.3. By Animal Type
      • 9.3.1.2.4. By End Use
  • 9.3.2. UAE Veterinary Excipients Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Application
      • 9.3.2.2.2. By Chemical Group
      • 9.3.2.2.3. By Animal Type
      • 9.3.2.2.4. By End Use
  • 9.3.3. South Africa Veterinary Excipients Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Application
      • 9.3.3.2.2. By Chemical Group
      • 9.3.3.2.3. By Animal Type
      • 9.3.3.2.4. By End Use

10. South America Veterinary Excipients Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Application
  • 10.2.2. By Chemical Group
  • 10.2.3. By Animal Type
  • 10.2.4. By End Use
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Veterinary Excipients Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Application
      • 10.3.1.2.2. By Chemical Group
      • 10.3.1.2.3. By Animal Type
      • 10.3.1.2.4. By End Use
  • 10.3.2. Colombia Veterinary Excipients Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Application
      • 10.3.2.2.2. By Chemical Group
      • 10.3.2.2.3. By Animal Type
      • 10.3.2.2.4. By End Use
  • 10.3.3. Argentina Veterinary Excipients Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Application
      • 10.3.3.2.2. By Chemical Group
      • 10.3.3.2.3. By Animal Type
      • 10.3.3.2.4. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Veterinary Excipients Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Croda International plc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. JRS PHARMA GmbH + Co. KG
• 15.3. Colorcon
• 15.4. Quality Chemicals S.L
• 15.5. IOI Oleo GmbH
• 15.6. Lipoid GmbH
• 15.7. Gattefosse SAS
• 15.8. Azelis Group
• 15.9. Ashland Global Holdings Inc.
• 15.10. Spectrum Chemical Mfg. Corp.

16. Strategic Recommendations

17. About Us & Disclaimer